The induction of human superoxide dismutase and catalase in vivo: A fundamentally new approach to antioxidant therapy, Free Radical Biology and Medicine (2006)
The results of a peer-reviewed study (Free Radical Biology and Medicine, 2006) showed Protandim eliminates the age-related increase in cell aging factors.
In the clinical trials, blood samples from men and women, young and old, consistently demonstrated that after 30 days, taking one caplet a day, test subjects realized a 40 percent average decrease in TBARS—the progressive aging rate of a 20 year old.
When maintained for 120 days, Protandim significantly increased activity of SOD and CAT antioxidant enzymes by 54 percent, substantially increasing the body’s antioxidant defenses.*
Click here to view the study.
Synergistic induction of heme oxygenase-1 by the components of an antioxidant supplement Protandim, Free Radical Biology and Medicine (2008)
Results of a new peer-reviewed study (Free Radical Biology & Medicine, on November 18, 2008) clearly demonstrate that Protandim produces a 300 percent increase in glutathione, which is a key antioxidant and anti-aging factor. In addition, the study shows that Protandim’s synergistic formulation provides more antioxidant power than any food or conventional supplement.
Click here to view the study.
Protandim has been issued four patents.
To date, there are nine completed, peer-reviewed published clinical studies and more than 20 on-going at numerous universities.
All clinical peer-reviewed studies are published on www.PubMeb.gov:
Significance of Peer Reviewed Science (pdf)
Peer-Review and Protanadim
Numerous universities have studied Protandim in their own funded trials. These universities include: